Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06296108 |
Other study ID # |
I05-310-22 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2022 |
Est. completion date |
December 31, 2022 |
Study information
Verified date |
March 2024 |
Source |
Ankara University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The authors aimed to determine the risk factors associated with postoperative acute kidney
injury in patients undergoing total joint arthroplasty.
Description:
Aim: The primary aim of the current study is to determine the risk factors associated with
postoperative acute kidney injury in patients undergoing total joint arthroplasty.
Considering that this patient group is mostly composed of advanced age and comorbid patients,
the secondary aim of the study is to identify risky patients with predictable risk factors
and to chart a way to make preoperative optimizations of the patients before developing
postoperative complications.
Materials and Methods: Patients who underwent joint arthroplasty between 2015 and 2020 in
Ankara University Faculty of Medicine, Department of Orthopedics and Traumatology were
included. Within the scope of the study, patients' gender, age, weight, height, body mass
index values, smoking, American Society of Anesthesiologist (ASA) score, Charlson-Comorbidity
Index score (CCI), type of operation, duration of surgery, presence of intraoperative
hypotension, anesthesia method , diabetes, hypertension, coronary artery disease, presence of
congestive heart failure, presence of preoperative anemia, preoperative uric acid and albumin
level, use of nephrotoxic agents in the perioperative period, basal creatinine and glomerular
filtration rate (GFR) values, platelet suspension in the perioperative period, erythrocyte
suspension, Amounts of fresh frozen plasma transfusions, postoperative creatinine at 24 hours
- 48 hours - discharge, GFR values and Kidney Disesae Improving Global Outcomes (KDIGO)
scores, length of hospital stay and length of stay in the intensive care unit were evaluated.